speb/financial-data huggingface dataset:
Financial ratios for CGX.TO — quarterly report dated 2025-12-31
Total revenue: 244356204.37956202
Gross profit: 166786131.3868613
Operating income: 27758394.16058394
Net income: 269343.06569343066
Capital expenditures: 8429927.007299269
Operating cash flow: 59154744.52554744
Depreciation & amortization: 28939416.05839416
Net tangible assets: -535609489.05109483
Owner earnings: 20778832.11678832
Return on net tangible assets (%): -3.879474232915636
Capex to operating income (%): 30.36892897525572
Buffett classification: The Good
Stock price: 7.693430656934305
P/E ratio: 453.20814607046066
Shares outstanding: 63466340
Book value: -58023357.664233446
Market cap (USD): 488273885.83941597
Debt to equity: -22.563905801841745
Current ratio: 0.5209874077437759
Quick ratio: 0.49102639229880757
Interest coverage ratio: 1.0631534805703102
COGS to revenue (%): 31.74467093629021
SG&A to revenue (%): 25.18490417244181
Free cash flow (dilution-adjusted): 49532846.71532846
Buyback yield (%): 1.0684143617878399
Retained earnings: -768532846.7153285
Inventory turnover: 6.683290359096913
Receivables turnover: 2.95428712626637
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.295387917479751
FCF margin (%): 20.270754671892178
Rule of 40 score: 20.270754671892178
Financial ratios for EMAN.L — annual report dated 2021-12-31
Total revenue: 66252702.7027027
Gross profit: 41754054.05405405
Operating income: -10089189.18918919
Net income: -7337837.837837838
Capital expenditures: 9987837.837837838
Operating cash flow: 16489189.18918919
Depreciation & amortization: 15847297.297297297
Net tangible assets: 53127027.027027026
Owner earnings: -1478378.3783783782
Return on net tangible assets (%): -2.782723711654881
Buffett classification: The Gruesome
Stock price: 0.01743243243243243
Shares outstanding: 91622821
Book value: 65162162.162162185
P/B ratio: 0.02451128973247614
Market cap (USD): 1597208.6363513512
Debt to equity: 1.9576731646619654
Current ratio: 0.5538429385025341
Quick ratio: 0.5166936621558076
Interest coverage ratio: -2.339705421497963
COGS to revenue (%): 36.977583780365926
SG&A to revenue (%): 80.28841250739389
Free cash flow (dilution-adjusted): 4482432.432432433
Buyback yield (%): 0
Retained earnings: -39498648.64864865
Inventory turnover: 25.49789029535865
Receivables turnover: 8.678881217914675
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.295598822569777
FCF margin (%): 6.765659738511433
Rule of 40 score: 6.765659738511433
Financial ratios for EMAN.L — annual report dated 2022-12-31
Total revenue: 94960240.96385543
Gross profit: 60818072.28915663
Operating income: 484337.3493975904
Net income: -4221686.746987952
Capital expenditures: 22751807.228915665
Operating cash flow: 14213253.012048194
Depreciation & amortization: 14126506.024096387
Net tangible assets: 44526506.024096385
Owner earnings: -12846987.95180723
Return on net tangible assets (%): -28.852450144762837
Capex to operating income (%): 4697.512437810946
Buffett classification: The Gruesome
Stock price: 0.01
Shares outstanding: 91622821
Book value: 55745783.13253012
P/B ratio: 0.01643582991419741
Market cap (USD): 916228.21
Debt to equity: 2.3443990576844107
Current ratio: 0.5432774001699235
Quick ratio: 0.5066376380628717
Interest coverage ratio: 0.10452418096723869
COGS to revenue (%): 35.95417232322976
SG&A to revenue (%): 64.324955276146
Free cash flow (dilution-adjusted): -11665060.240963856
Buyback yield (%): 0
Retained earnings: -37585542.1686747
Inventory turnover: 41.06956521739131
Receivables turnover: 13.496061643835619
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.2625906329610034
FCF margin (%): -12.284151896164532
Revenue growth (%): 43.33036553991274
Rule of 40 score: 31.04621364374821
Financial ratios for EMAN.L — annual report dated 2023-12-31
Total revenue: 115011392.40506329
Gross profit: 73588607.5949367
Operating income: -65822.78481012658
Net income: -3412658.227848101
Capital expenditures: 23526582.27848101
Operating cash flow: 22640506.329113923
Depreciation & amortization: 16648101.265822785
Net tangible assets: 44310126.58227848
Owner earnings: -10291139.240506327
Return on net tangible assets (%): -23.22525353520925
Buffett classification: The Gruesome
Stock price: 0.008227848101265823
Shares outstanding: 91622821
Book value: 56193670.88607594
P/B ratio: 0.013415365857229746
Market cap (USD): 753858.6537974684
Debt to equity: 2.9112247426396056
Current ratio: 0.5708963598007092
Quick ratio: 0.532384756946003
Interest coverage ratio: -0.009717809755185948
COGS to revenue (%): 36.01624495096799
SG&A to revenue (%): 64.75307894649951
Free cash flow (dilution-adjusted): -2973417.7215189873
Buyback yield (%): 0
Retained earnings: -41863291.1392405
Inventory turnover: 38.13986013986014
Receivables turnover: 17.41928680981595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.030155766130435288
FCF margin (%): -2.585324513807108
Revenue growth (%): 21.115312300902747
Rule of 40 score: 18.52998778709564
Financial ratios for EMAN.L — annual report dated 2024-12-31
Total revenue: 133966250
Gross profit: 86333750
Operating income: -4202500
Net income: -10668750
Capital expenditures: 19291250
Operating cash flow: 26968750
Depreciation & amortization: 18583750
Net tangible assets: 34006250
Owner earnings: -11376250
Return on net tangible assets (%): -33.45340929976107
Buffett classification: The Gruesome
Stock price: 0.006625
Shares outstanding: 91622821
Book value: 45565000
P/B ratio: 0.01332165454021727
Market cap (USD): 607001.189125
Debt to equity: 3.6823219576429276
Current ratio: 0.6023256582207394
Quick ratio: 0.5704799973572066
Interest coverage ratio: -0.5035195447057061
COGS to revenue (%): 35.5555970253702
SG&A to revenue (%): 68.05352094277477
Free cash flow (dilution-adjusted): 6135000
Buyback yield (%): 0
Retained earnings: -51266250
Inventory turnover: 39.52904564315353
Receivables turnover: 14.510289737340916
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.9761358960794686
FCF margin (%): 4.579511630727889
Revenue growth (%): 16.480852199561962
Rule of 40 score: 21.06036383028985
Financial ratios for EMAN.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 34006250
Buffett classification: The Gruesome
Stock price: 0.006625
Shares outstanding: 91622821
Book value: 45565000
P/B ratio: 0.01332165454021727
Market cap (USD): 607001.189125
Debt to equity: 3.6823219576429276
Current ratio: 0.6023256582207394
Quick ratio: 0.5704799973572066
Buyback yield (%): 0
Retained earnings: -51266250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMAN.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 33520547.94520548
Buffett classification: The Gruesome
Stock price: 0.005753424657534247
Shares outstanding: 91622821
Book value: 46217808.21917808
P/B ratio: 0.011405668460831679
Market cap (USD): 527144.9975342465
Debt to equity: 4.045140638430303
Current ratio: 0.45450584561760227
Quick ratio: 0.4227361847360395
Buyback yield (%): 0
Retained earnings: -59898630.1369863
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FHYD.V — annual report dated 2022-03-31
Total revenue: 0
Gross profit: 0
Operating income: -6750188.8
Net income: -7094475.2
Capital expenditures: 0
Operating cash flow: -5721402.4
Depreciation & amortization: 0
Net tangible assets: 103643.2
Owner earnings: -7094475.2
Return on net tangible assets (%): -6845.094709541968
Buffett classification: The Gruesome
Stock price: 2.088
Shares outstanding: 81349963
Book value: 896543.1999999997
P/B ratio: 189.459607461191
Market cap (USD): 169858722.74400002
Debt to equity: 1.124147949591275
Current ratio: 1.4401878272557371
Quick ratio: 1.244814918098379
Interest coverage ratio: -20.427484760009488
Free cash flow (dilution-adjusted): -6301420
Buyback yield (%): 0
Retained earnings: -10135247.2
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 3634887.2
ROCI (R&D-adjusted, %): -79.47579640664948
Rule of 40 score: 0
Financial ratios for FHYD.V — annual report dated 2023-03-31
Total revenue: 0
Gross profit: 4110.37037037037
Operating income: -9892064.444444444
Net income: -10262540
Capital expenditures: 9150.37037037037
Operating cash flow: -10100872.592592591
Depreciation & amortization: 76311.85185185185
Net tangible assets: 146145.92592592593
Owner earnings: -10195378.518518519
Return on net tangible assets (%): -6976.1633476434
Buffett classification: The Gruesome
Stock price: 2.8074074074074074
Shares outstanding: 81349963
Book value: 806896.2962962962
P/B ratio: 283.0382166417274
Market cap (USD): 228382488.71851853
Debt to equity: 0.028272943422900737
Current ratio: 1.0599242936608715
Quick ratio: 0.9830008261239237
Interest coverage ratio: -73.4074703166227
Free cash flow (dilution-adjusted): -10774514.074074075
Buyback yield (%): 0
Retained earnings: -19646998.51851852
Inventory turnover: 0.6374873646209386
Receivables turnover: 0
Capitalized R&D asset: 6211909.238814814
ROCI (R&D-adjusted, %): -122.32907490125817
Rosenberg metric: 0.0011308109837274648
Rule of 40 score: 0
Financial ratios for FHYD.V — annual report dated 2024-03-31
Total revenue: 0
Operating income: -7750932.592592592
Net income: -8081384.444444444
Capital expenditures: 122576.29629629629
Operating cash flow: -6607799.259259258
Depreciation & amortization: 86930.37037037036
Net tangible assets: -2166482.222222222
Owner earnings: -8117030.37037037
Buffett classification: The Gruesome
Stock price: 0.7794117647058824
Shares outstanding: 81349963
Book value: -1579148.148148148
Market cap (USD): 63405118.22058824
Debt to equity: -1.0472472265872363
Current ratio: 0.5867794574773055
Quick ratio: 0.4950083389299851
Interest coverage ratio: -63.09626864771645
Free cash flow (dilution-adjusted): -7486630.370370369
Buyback yield (%): 0
Retained earnings: -27713404.444444444
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 4491682.953777777
ROCI (R&D-adjusted, %): -212.7213038402076
Rule of 40 score: 0
Financial ratios for FHYD.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3185185185185185
Shares outstanding: 81349963
Market cap (USD): 25911469.696296293
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FHYD.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -501860.83916083915
Net income: -618386.7132867133
Capital expenditures: 0
Operating cash flow: -203451.04895104896
Depreciation & amortization: 20544.755244755244
Net tangible assets: -4076701.398601399
Owner earnings: -597841.958041958
Buffett classification: The Gruesome
Stock price: 0.2517482517482518
Shares outstanding: 81349963
Book value: -3574206.993006993
Market cap (USD): 20479710.965034965
Debt to equity: -0.685064866459693
Current ratio: 0.1562709394952429
Quick ratio: 0.12144542083478635
Interest coverage ratio: -4.6819652666327425
Free cash flow (dilution-adjusted): -227663.63636363638
Buyback yield (%): 0
Retained earnings: -28987630.069930073
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 1531.4685314685316
Rule of 40 score: 0
Financial ratios for FHYD.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -513166.4335664336
Net income: -732770.6293706294
Capital expenditures: 0
Operating cash flow: -167488.1118881119
Depreciation & amortization: 21078.321678321678
Net tangible assets: -4456538.461538462
Owner earnings: -711692.3076923077
Buffett classification: The Gruesome
Stock price: 0.32867132867132864
Shares outstanding: 81349963
Book value: -3971371.3286713287
Market cap (USD): 26737400.426573426
Debt to equity: -0.6487364724555696
Current ratio: 0.14480677468549805
Quick ratio: 0.11113670543373497
Interest coverage ratio: -4.647216399526303
Free cash flow (dilution-adjusted): -180500.6993006993
Buyback yield (%): 0
Retained earnings: -29706232.16783217
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 74368.04195804195
Rule of 40 score: 0
Financial ratios for FHYD.V — annual report dated 2025-03-31
Total revenue: 0
Operating income: -2956926.5734265735
Net income: -3543227.9720279723
Capital expenditures: 0
Operating cash flow: -1072390.2097902098
Depreciation & amortization: 82561.53846153847
Net tangible assets: -4456538.461538462
Owner earnings: -3460666.433566434
Buffett classification: The Gruesome
Stock price: 0.32867132867132864
Shares outstanding: 81349963
Book value: -3971371.3286713287
Market cap (USD): 26737400.426573426
Debt to equity: -0.6487364724555696
Current ratio: 0.14480677468549805
Quick ratio: 0.11113670543373497
Interest coverage ratio: -7.2866975362361295
Free cash flow (dilution-adjusted): -1675216.7832167833
Buyback yield (%): 0
Retained earnings: -29706232.16783217
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 1922752.0016576017
Rule of 40 score: 0
Financial ratios for FHYD.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -854752.5547445255
Net income: -986743.7956204378
Capital expenditures: 0
Operating cash flow: -89231.38686131386
Depreciation & amortization: 19429.197080291968
Net tangible assets: -4700308.759124087
Owner earnings: -967314.5985401459
Buffett classification: The Gruesome
Stock price: 0.5036496350364963
Shares outstanding: 81349963
Book value: -4211979.562043795
Market cap (USD): 40971879.17518248
Debt to equity: -0.6321571146046417
Current ratio: 0.09612539017164111
Quick ratio: 0.060592417281516604
Interest coverage ratio: -16.848594285056546
Free cash flow (dilution-adjusted): -647489.7810218977
Buyback yield (%): 0
Retained earnings: -31993978.832116786
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 62710.91986116075
Rule of 40 score: 0
Financial ratios for FHYD.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -33726.61870503597
Net income: -154182.73381294965
Capital expenditures: 0
Operating cash flow: -234056.8345323741
Depreciation & amortization: 19055.39568345324
Net tangible assets: -4728408.633093526
Owner earnings: -135127.3381294964
Buffett classification: The Gruesome
Stock price: 0.3309352517985612
Shares outstanding: 81349963
Book value: -4264932.37410072
Market cap (USD): 26921570.48920864
Debt to equity: -0.6127238769715747
Current ratio: 0.06355747666641241
Quick ratio: 0.030084223814646982
Interest coverage ratio: -0.31124684636834415
Free cash flow (dilution-adjusted): -94070.5035971223
Buyback yield (%): 0
Retained earnings: -31687816.546762593
Inventory turnover: 0
Receivables turnover: 0
Capitalized R&D asset: 41042.241889812125
Rule of 40 score: 0
Financial ratios for FTE.DE — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 9817045454.545454
Buffett classification: The Gruesome
Stock price: 8.068181818181818
Shares outstanding: 2657769336
Market cap (USD): 21443366233.636364
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FTE.DE — annual report dated 2022-12-31
Total revenue: 41625531914.893616
Gross profit: 24429787234.042553
Operating income: 5931914893.617022
Net income: 2784042553.1914897
Capital expenditures: 8811702127.659575
Operating cash flow: 11952127659.574469
Depreciation & amortization: 9201063829.787235
Net tangible assets: -6675531914.893618
Owner earnings: 3173404255.319151
Return on net tangible assets (%): -47.537848605577715
Capex to operating income (%): 148.5473457675753
Buffett classification: The Gruesome
Stock price: 8.02127659574468
P/E ratio: 7.657463046786396
Shares outstanding: 2657769336
Book value: 37187234042.55319
P/B ratio: 0.5732801462821833
Market cap (USD): 21318702971.74468
Debt to equity: 0.9157798375100127
Current ratio: 0.9171913495756912
Quick ratio: 0.8813304133588831
Effective tax rate (%): 33.7966537966538
Interest coverage ratio: 6.188679245283018
COGS to revenue (%): 41.31057043549377
SG&A to revenue (%): 22.796974033939893
Free cash flow (dilution-adjusted): 2600000000.0000005
Buyback yield (%): 0
Retained earnings: -708510638.2978724
Inventory turnover: 15.423664122137405
Receivables turnover: 4.212294111314458
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.933081341854624
FCF margin (%): 6.246166428133307
Rule of 40 score: 6.246166428133307
Financial ratios for FTE.DE — annual report dated 2023-12-31
Total revenue: 44085555555.55556
Gross profit: 25461111111.11111
Operating income: 5721111111.111111
Net income: 3213333333.3333335
Capital expenditures: 8495555555.555555
Operating cash flow: 13393333333.333332
Depreciation & amortization: 9958888888.88889
Net tangible assets: -7832222222.222222
Owner earnings: 4676666666.666668
Return on net tangible assets (%): -59.71059724783658
Capex to operating income (%): 148.49485336958634
Buffett classification: The Gruesome
Stock price: 9.822222222222221
P/E ratio: 8.12402521792531
Shares outstanding: 2657769336
Book value: 38998888888.888885
P/B ratio: 0.6693831998131
Market cap (USD): 26105201033.6
Debt to equity: 0.24410951878970913
Current ratio: 0.8268147274633123
Quick ratio: 0.7890788784067085
Effective tax rate (%): 24.551066217732885
Interest coverage ratio: 3.9516500383729856
COGS to revenue (%): 42.24613756080348
SG&A to revenue (%): 22.728532903193287
Free cash flow (dilution-adjusted): 4528888888.888889
Buyback yield (%): 0
Retained earnings: -694444444.4444444
Inventory turnover: 14.550347222222221
Receivables turnover: 3.1797563712133354
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.474774910718777
FCF margin (%): 10.272954104392975
Revenue growth (%): 5.909891183352651
Rule of 40 score: 16.182845287745625
Financial ratios for FTE.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.239583333333332
Shares outstanding: 2657769336
Market cap (USD): 24556681260.749996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FTE.DE — annual report dated 2024-12-31
Total revenue: 41936458333.333336
Gross profit: 24593750000
Operating income: 6277083333.333334
Net income: 3022916666.666667
Capital expenditures: 7039583333.333334
Operating cash flow: 10619791666.666668
Depreciation & amortization: 8263541666.666667
Net tangible assets: -1858333333.3333335
Owner earnings: 4246875000
Return on net tangible assets (%): -228.53139013452912
Capex to operating income (%): 112.14736143378691
Buffett classification: The Gruesome
Stock price: 9.239583333333332
P/E ratio: 8.123505861585112
Shares outstanding: 2657769336
Book value: 36626041666.66667
P/B ratio: 0.6704705216097379
Market cap (USD): 24556681260.749996
Debt to equity: 0.20949347288188616
Current ratio: 0.920808399326334
Quick ratio: 0.8924642562797865
Effective tax rate (%): 33.46505309953075
Interest coverage ratio: 4.592987804878049
COGS to revenue (%): 41.35472813532378
SG&A to revenue (%): -21.008966939069527
Free cash flow (dilution-adjusted): 3280208333.3333335
Buyback yield (%): 0
Retained earnings: -704166666.6666667
Inventory turnover: 21.048040455120102
Receivables turnover: 6.896026036313806
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.932391696394488
FCF margin (%): 7.821853498596587
Revenue growth (%): -4.874833026690524
Rule of 40 score: 2.947020471906063
Financial ratios for FTE.DE — quarterly report dated 2025-03-31
Total revenue: 10772826086.956522
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.01086956521739
Shares outstanding: 2657769336
Market cap (USD): 31922120829.130432
COGS to revenue (%): 0
SG&A to revenue (%): -37.72575925739077
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FTE.DE — quarterly report dated 2025-06-30
Total revenue: 11696470588.235294
Capital expenditures: 0
Net tangible assets: -4807058823.529412
Buffett classification: The Gruesome
Stock price: 14.423529411764706
Shares outstanding: 2657769336
Book value: 38378823529.41176
P/B ratio: 0.9988428685966527
Market cap (USD): 38334414187.48235
Debt to equity: 0.2301514315492613
Current ratio: 0.8911427397362621
Quick ratio: 0.8608838581941799
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: -3036470588.2352943
Inventory turnover: 0
Receivables turnover: 1.8441847523650527
Capitalized R&D asset: 0
Revenue growth (%): 8.5738365571231
Rule of 40 score: 8.5738365571231
Financial ratios for FTE.DE — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.505882352941176
Shares outstanding: 2657769336
Market cap (USD): 41211058645.27059
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FTE.DE — annual report dated 2025-12-31
Total revenue: 47525882352.94118
Gross profit: 28245882352.941177
Operating income: 4894117647.058824
Net income: 1340000000
Capital expenditures: 8214117647.058824
Operating cash flow: 12682352941.176472
Depreciation & amortization: 10058823529.411764
Net tangible assets: -4149411764.7058825
Owner earnings: 3184705882.3529406
Return on net tangible assets (%): -76.75077969946128
Capex to operating income (%): 167.83653846153845
Buffett classification: The Gruesome
Stock price: 16.28235294117647
P/E ratio: 32.2945808693942
Shares outstanding: 2657769336
Book value: 39005882352.94118
P/B ratio: 1.1094413394733824
Market cap (USD): 43274738364.988235
Debt to equity: 0.2268737746946162
Current ratio: 1.11416123684312
Quick ratio: 1.085514901492077
Effective tax rate (%): 49.37701892016612
Interest coverage ratio: 3.1021625652498135
COGS to revenue (%): 40.56736886402456
SG&A to revenue (%): -24.3582444240909
Free cash flow (dilution-adjusted): 3876470588.2352943
Buyback yield (%): 0
Retained earnings: -2660000000
Inventory turnover: 22.056527590847914
Receivables turnover: 7.821297192642787
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.105672696924322
FCF margin (%): 8.156546278188975
Revenue growth (%): 13.328316795805975
Rule of 40 score: 21.48486307399495
Financial ratios for FTE.DE — quarterly report dated 2025-12-31
Total revenue: 12411764705.882353
Capital expenditures: 0
Net tangible assets: -4149411764.7058825
Buffett classification: The Gruesome
Stock price: 16.28235294117647
Shares outstanding: 2657769336
Book value: 39005882352.94118
P/B ratio: 1.1094413394733824
Market cap (USD): 43274738364.988235
Debt to equity: 0.2268737746946162
Current ratio: 1.11416123684312
Quick ratio: 1.085514901492077
COGS to revenue (%): 0
SG&A to revenue (%): -18.748815165876778
Buyback yield (%): 0
Retained earnings: -2660000000
Inventory turnover: 0
Receivables turnover: 2.0425943852855757
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GBT.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.034090909090914
Shares outstanding: 12553034
Market cap (USD): 489996270.3409091
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GBT.PA — annual report dated 2022-12-31
Total revenue: 818614893.6170213
Gross profit: 593973404.2553192
Operating income: 45661702.127659574
Net income: -43740425.5319149
Capital expenditures: 45362765.95744681
Operating cash flow: 32384042.55319149
Depreciation & amortization: 130993617.02127661
Net tangible assets: 299622340.4255319
Owner earnings: 41890425.53191489
Capex to operating income (%): 99.34532407623131
Buffett classification: The Gruesome
Stock price: 17.27659574468085
Shares outstanding: 12553034
Book value: 403797872.3404255
P/B ratio: 0.5370847858366047
Market cap (USD): 216873693.78723404
Debt to equity: 0.821598124193166
Current ratio: 2.127005258325682
Quick ratio: 0.9898046907603704
Interest coverage ratio: 9.385961075880166
COGS to revenue (%): 27.441656768438644
SG&A to revenue (%): 2.1260614062674623
Free cash flow (dilution-adjusted): -20939361.70212766
Buyback yield (%): 0
Retained earnings: -43740425.5319149
Inventory turnover: 0.7749214667371264
Receivables turnover: 6.347003414770946
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.131512821721572
FCF margin (%): -2.5579013850588304
Rule of 40 score: -2.5579013850588304
Financial ratios for GBT.PA — annual report dated 2023-12-31
Total revenue: 884060000
Gross profit: 654322222.2222222
Operating income: 43518888.88888889
Net income: 26517777.777777776
Capital expenditures: 45371111.11111111
Operating cash flow: 30485555.555555556
Depreciation & amortization: 67938888.88888888
Net tangible assets: 312463333.3333333
Owner earnings: 49085555.555555545
Return on net tangible assets (%): 15.70922099304096
Capex to operating income (%): 104.25613399034903
Buffett classification: The Gruesome
Stock price: 21.355555555555554
P/E ratio: 10.109331831056734
Shares outstanding: 12553034
Book value: 420302222.2222221
P/B ratio: 0.6378196469207345
Market cap (USD): 268077014.97777775
Debt to equity: 1.02243359275865
Current ratio: 2.537366889589795
Quick ratio: 1.2060315756869826
Effective tax rate (%): 28.034925993248507
Interest coverage ratio: 3.683186007146887
COGS to revenue (%): 25.986672598893485
SG&A to revenue (%): 1.975230439361833
Free cash flow (dilution-adjusted): -29791111.11111111
Buyback yield (%): 0
Retained earnings: 26517777.777777776
Inventory turnover: 0.6775193493633223
Receivables turnover: 5.32035653865957
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.9203846661181005
FCF margin (%): -3.369806473668202
Revenue growth (%): 7.994614670863336
Rule of 40 score: 4.624808197195134
Financial ratios for GBT.PA — annual report dated 2024-12-31
Total revenue: 886578125
Gross profit: 652832291.6666667
Operating income: 50830208.333333336
Net income: 16754166.666666668
Capital expenditures: 32086458.333333336
Operating cash flow: 84604166.66666667
Depreciation & amortization: 76195833.33333334
Net tangible assets: 299532291.6666667
Owner earnings: 60863541.66666668
Return on net tangible assets (%): 20.31952592757459
Capex to operating income (%): 63.12478226120458
Buffett classification: The Good
Stock price: 27.916666666666668
P/E ratio: 20.91652021885103
Shares outstanding: 12553034
Book value: 407886458.3333334
P/B ratio: 0.8591578824785288
Market cap (USD): 350438865.8333334
Debt to equity: 1.0090737056625745
Current ratio: 2.318296310559055
Quick ratio: 1.1345983818172531
Effective tax rate (%): 30.39276485788114
Interest coverage ratio: 2.3777896891141213
COGS to revenue (%): 26.36494480769344
SG&A to revenue (%): 1.7446526027622589
Free cash flow (dilution-adjusted): 24489583.333333336
Buyback yield (%): 0
Retained earnings: 16754166.666666668
Inventory turnover: 0.7449299706869479
Receivables turnover: 4.922585309427414
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.23387938490312
FCF margin (%): 2.7622589191824845
Revenue growth (%): 0.28483643644096557
Rule of 40 score: 3.04709535562345
Financial ratios for GBT.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 299532291.6666667
Buffett classification: The Gruesome
Stock price: 27.916666666666668
Shares outstanding: 12553034
Book value: 407886458.3333334
P/B ratio: 0.8591578824785288
Market cap (USD): 350438865.8333334
Debt to equity: 1.0090737056625745
Current ratio: 2.318296310559055
Quick ratio: 1.1345983818172531
Buyback yield (%): 0
Retained earnings: 16754166.666666668
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GNLX — annual report dated 2023-12-31
Total revenue: 170000
Operating income: -24165000
Net income: -28297000
Capital expenditures: 1025000
Operating cash flow: -20275000
Depreciation & amortization: 1018000
Net tangible assets: 19473000
Owner earnings: -28304000
Return on net tangible assets (%): -145.3499717557644
Buffett classification: The Gruesome
Stock price: 14.01
Shares outstanding: 44840416
Book value: 19473000
P/B ratio: 32.26078304113388
Market cap (USD): 628214228.16
Debt to equity: 0.12935859908591382
Current ratio: 3.6928593225511137
Quick ratio: 3.6928593225511137
Interest coverage ratio: -29.3978102189781
COGS to revenue (%): 0
R&D to revenue (%): 7509.999999999999
SG&A to revenue (%): 6804.705882352941
Free cash flow (dilution-adjusted): -26504000
Buyback yield (%): 0
Retained earnings: -221524000
Capitalized R&D asset: 18849260
ROCI (R&D-adjusted, %): -46.48040663284917
FCF margin (%): -15590.588235294117
Revenue growth (%): 137.15369805619065
Rule of 40 score: -15453.434537237927
Financial ratios for GNLX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.37
Shares outstanding: 44840416
Market cap (USD): 106271785.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GNLX — annual report dated 2024-12-31
Total revenue: 8000
Operating income: -31696000
Net income: -29869000
Capital expenditures: 381000
Operating cash flow: -21228000
Depreciation & amortization: 903000
Net tangible assets: 26274000
Owner earnings: -29347000
Return on net tangible assets (%): -111.69597320545026
Buffett classification: The Gruesome
Stock price: 2.36
Shares outstanding: 44840416
Book value: 26274000
P/B ratio: 4.027684469818071
Market cap (USD): 105823381.75999999
Debt to equity: 0.07109690188018573
Current ratio: 4.570186875271621
Quick ratio: 4.570186875271621
COGS to revenue (%): 0
R&D to revenue (%): 237475
SG&A to revenue (%): 158825
Free cash flow (dilution-adjusted): -27679000
Buyback yield (%): 0
Retained earnings: -251393000
Capitalized R&D asset: 30547630
ROCI (R&D-adjusted, %): -45.0857595837011
FCF margin (%): -345987.5
Revenue growth (%): -95.29411764705881
Rule of 40 score: -346082.79411764705
Financial ratios for GNLX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.36
Shares outstanding: 44840416
Market cap (USD): 105823381.75999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GNLX — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -7816000
Net income: -7492000
Capital expenditures: 30000
Operating cash flow: -5435000
Depreciation & amortization: 139000
Net tangible assets: 29846000
Owner earnings: -7383000
Return on net tangible assets (%): -24.736983180325673
Buffett classification: The Gruesome
Stock price: 2.7
Shares outstanding: 44840416
Book value: 29846000
P/B ratio: 4.056460604436105
Market cap (USD): 121069123.2
Debt to equity: 0.0598740199691751
Current ratio: 4.674860189881649
Quick ratio: 4.674860189881649
Free cash flow (dilution-adjusted): -6894000
Buyback yield (%): 0
Retained earnings: -258885000
Capitalized R&D asset: 4698000
ROCI (R&D-adjusted, %): -13.01327999110963
Rule of 40 score: 0
Financial ratios for GNLX — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -7792000
Net income: -7456000
Capital expenditures: 115000
Operating cash flow: -7059000
Depreciation & amortization: 143000
Net tangible assets: 23898000
Owner earnings: -7428000
Return on net tangible assets (%): -31.08209892041175
Buffett classification: The Gruesome
Stock price: 2.87
Shares outstanding: 44840416
Book value: 23898000
P/B ratio: 5.385052888107792
Market cap (USD): 128691993.92
Debt to equity: 0.07138672692275504
Current ratio: 4.183600457927876
Quick ratio: 4.183600457927876
Free cash flow (dilution-adjusted): -8471000
Buyback yield (%): 0
Retained earnings: -266341000
Capitalized R&D asset: 7905660
ROCI (R&D-adjusted, %): -18.652384797552575
Rule of 40 score: 0
Financial ratios for GNLX — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -8194000
Net income: -7950000
Capital expenditures: 517000
Operating cash flow: -6575000
Depreciation & amortization: 144000
Net tangible assets: 18591000
Owner earnings: -8323000
Return on net tangible assets (%): -44.76897423484482
Buffett classification: The Gruesome
Stock price: 4.2
Shares outstanding: 44840416
Book value: 18591000
P/B ratio: 10.130156914636114
Market cap (USD): 188329747.20000002
Debt to equity: 0.08735409606798988
Current ratio: 4.2044479126024195
Quick ratio: 4.2044479126024195
Free cash flow (dilution-adjusted): -9440000
Buyback yield (%): 0
Retained earnings: -274291000
Capitalized R&D asset: 9479200
ROCI (R&D-adjusted, %): -27.89801478290309
Rule of 40 score: 0
Financial ratios for GNLX — quarterly report dated 2025-12-31
Total revenue: 8000
Operating income: -9412000
Net income: -9247000
Capital expenditures: 436000
Operating cash flow: -6199000
Depreciation & amortization: 148000
Net tangible assets: 11544000
Owner earnings: -9535000
Return on net tangible assets (%): -82.5970200970201
Buffett classification: The Gruesome
Stock price: 4.36
Shares outstanding: 44840416
Book value: 11544000
P/B ratio: 16.935569452529453
Market cap (USD): 195504213.76000002
Debt to equity: 0.14596327096327097
Current ratio: 2.4305220883534138
Quick ratio: 2.4305220883534138
COGS to revenue (%): 0
R&D to revenue (%): 70675
SG&A to revenue (%): 47075
Free cash flow (dilution-adjusted): -8238000
Buyback yield (%): 0
Retained earnings: -283538000
Capitalized R&D asset: 10400610
ROCI (R&D-adjusted, %): -37.965556461105024
FCF margin (%): -102975
Rule of 40 score: -102975
Financial ratios for GNLX — annual report dated 2025-12-31
Total revenue: 8000
Operating income: -33214000
Net income: -32145000
Capital expenditures: 1098000
Operating cash flow: -25268000
Depreciation & amortization: 574000
Net tangible assets: 11544000
Owner earnings: -32669000
Return on net tangible assets (%): -282.9954954954955
Buffett classification: The Gruesome
Stock price: 4.36
Shares outstanding: 44840416
Book value: 11544000
P/B ratio: 16.935569452529453
Market cap (USD): 195504213.76000002
Debt to equity: 0.14596327096327097
Current ratio: 2.4305220883534138
Quick ratio: 2.4305220883534138
COGS to revenue (%): 0
R&D to revenue (%): 248137.5
SG&A to revenue (%): 167137.5
Free cash flow (dilution-adjusted): -33043000
Buyback yield (%): 0
Retained earnings: -283538000
Capitalized R&D asset: 36792770
ROCI (R&D-adjusted, %): -61.636203441075196
FCF margin (%): -413037.5
Revenue growth (%): 0
Rule of 40 score: -413037.5
Financial ratios for GPOR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 72.03
Shares outstanding: 17969641
Market cap (USD): 1294353241.23
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GPOR — annual report dated 2022-12-31
Total revenue: 2330859000
Gross profit: 1998308000
Operating income: 1542873000
Net income: 494701000
Capital expenditures: 457420000
Operating cash flow: 739077000
Depreciation & amortization: 267761000
Net tangible assets: 881130000
Owner earnings: 305042000
Return on net tangible assets (%): 34.6194091677732
Capex to operating income (%): 29.647287884356004
Buffett classification: The Good
Stock price: 73.64
P/E ratio: 2.6749175021679763
Shares outstanding: 17969641
Book value: 881130000
P/B ratio: 1.5018037783754952
Market cap (USD): 1323284363.24
Debt to equity: 0.8181176443884557
Current ratio: 0.507071547420965
Quick ratio: 0.507071547420965
Effective tax rate (%): 0
Interest coverage ratio: 27.13507096501873
COGS to revenue (%): 14.267315182943285
SG&A to revenue (%): 1.5146347333751204
Free cash flow (dilution-adjusted): 272574000
Buyback yield (%): 18.928811293946413
Retained earnings: 381872000
Receivables turnover: 7.772587217638938
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 88.61183843635187
FCF margin (%): 11.694143661199584
Rule of 40 score: 11.694143661199584
Financial ratios for GPOR — annual report dated 2023-12-31
Total revenue: 1051383000
Gross profit: 663020000
Operating income: 239290000
Net income: 1470916000
Capital expenditures: 534701000
Operating cash flow: 723181000
Depreciation & amortization: 319715000
Net tangible assets: 2205894000
Owner earnings: 1255930000
Return on net tangible assets (%): 56.93519271551579
Capex to operating income (%): 223.45313218270718
Buffett classification: The Gruesome
Stock price: 133.2
P/E ratio: 1.6272555205055894
Shares outstanding: 17969641
Book value: 2205894000
P/B ratio: 1.0850730729581746
Market cap (USD): 2393556181.2
Debt to equity: 0.30902708833697357
Current ratio: 1.1519854610484999
Quick ratio: 1.1519854610484999
Effective tax rate (%): -55.52740653019793
Interest coverage ratio: 4.44611668524712
COGS to revenue (%): 36.938299363790364
SG&A to revenue (%): 3.6713547774692956
Free cash flow (dilution-adjusted): 176341000
Buyback yield (%): 6.2319406233956345
Retained earnings: 1847948000
Receivables turnover: 7.265950241879751
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.1860069876459
FCF margin (%): 16.772289451132462
Revenue growth (%): -54.892895709264266
Rule of 40 score: -38.1206062581318
Financial ratios for GPOR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 151.35
Shares outstanding: 17969641
Market cap (USD): 2719705165.35
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GPOR — annual report dated 2024-12-31
Total revenue: 928604000
Gross profit: 532769000
Operating income: 106930000
Net income: -261386000
Capital expenditures: 453873000
Operating cash flow: 650033000
Depreciation & amortization: 325723000
Net tangible assets: 1748741000
Owner earnings: -389536000
Return on net tangible assets (%): -22.275225433611954
Capex to operating income (%): 424.4580566725896
Buffett classification: The Gruesome
Stock price: 184.2
Shares outstanding: 17969641
Book value: 1748741000
P/B ratio: 1.8927948004878938
Market cap (USD): 3310007872.2
Debt to equity: 0.4054093773749229
Current ratio: 0.6694866689049168
Quick ratio: 0.6694866689049168
Interest coverage ratio: 1.9172015634525048
COGS to revenue (%): 42.626889395264286
SG&A to revenue (%): 4.583008472933565
Free cash flow (dilution-adjusted): 184977000
Buyback yield (%): 5.573310007791226
Retained earnings: 1582332000
Receivables turnover: 5.639215638644797
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.2429357480728624
FCF margin (%): 19.919901271155414
Revenue growth (%): -11.677856689712502
Rule of 40 score: 8.242044581442912
Financial ratios for GPOR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 184.2
Shares outstanding: 17969641
Market cap (USD): 3310007872.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GPOR — quarterly report dated 2025-03-31
Total revenue: 343582000
Gross profit: 257677000
Operating income: 158562000
Net income: -464000
Capital expenditures: 108231000
Operating cash flow: 177280000
Depreciation & amortization: 65622000
Net tangible assets: 1688386000
Owner earnings: -43073000
Return on net tangible assets (%): -2.551134633904806
Capex to operating income (%): 68.25784235819428
Buffett classification: The Good
Stock price: 184.14
Shares outstanding: 17969641
Book value: 1688386000
P/B ratio: 1.9598182487535432
Market cap (USD): 3308929693.74
Debt to equity: 0.41548792752368235
Current ratio: 0.42990086652789933
Quick ratio: 0.42990086652789933
Interest coverage ratio: 13.508434145510309
COGS to revenue (%): 25.00276498768853
SG&A to revenue (%): 2.619753072046848
Free cash flow (dilution-adjusted): 66009000
Buyback yield (%): 1.7470603896288877
Retained earnings: 1581006000
Receivables turnover: 2.0597576840300467
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.419392019666023
FCF margin (%): 19.21200761390294
Rule of 40 score: 19.21200761390294
Financial ratios for GPOR — quarterly report dated 2025-06-30
Total revenue: 311515000
Gross profit: 220244000
Operating income: 114667000
Net income: 184466000
Capital expenditures: 144769000
Operating cash flow: 231403000
Depreciation & amortization: 73643000
Net tangible assets: 1797035000
Owner earnings: 113340000
Return on net tangible assets (%): 6.3070557891193
Capex to operating income (%): 126.25166787305851
Buffett classification: The Gruesome
Stock price: 201.17
P/E ratio: 19.646268409962936
Shares outstanding: 17969641
Book value: 1797035000
P/B ratio: 2.0116206306332374
Market cap (USD): 3614952679.97
Debt to equity: 0.38736641189514953
Current ratio: 0.5079911400624713
Quick ratio: 0.5079911400624713
Effective tax rate (%): 21.881458142765187
Interest coverage ratio: 9.471132402742215
COGS to revenue (%): 29.29907067075422
SG&A to revenue (%): 3.507375246777844
Free cash flow (dilution-adjusted): 83371000
Buyback yield (%): 1.844865089646304
Retained earnings: 1764668000
Receivables turnover: 2.219368490047164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.462032237051519
FCF margin (%): 26.763077219395537
Revenue growth (%): -9.333143179794053
Rule of 40 score: 17.429934039601484
Financial ratios for GPOR — quarterly report dated 2025-09-30
Total revenue: 312941000
Gross profit: 208932000
Operating income: 92185000
Net income: 111393000
Capital expenditures: 129749000
Operating cash flow: 209078000
Depreciation & amortization: 83216000
Net tangible assets: 1834309000
Owner earnings: 64860000
Return on net tangible assets (%): 3.5359364207448145
Capex to operating income (%): 140.74849487443728
Buffett classification: The Gruesome
Stock price: 180.98
P/E ratio: 11.009480960002707
Shares outstanding: 17969641
Book value: 1834309000
P/B ratio: 1.772954081444293
Market cap (USD): 3252145628.18
Debt to equity: 0.37748601789556724
Current ratio: 0.5400946331158025
Quick ratio: 0.5400946331158025
Effective tax rate (%): 21.99533623243209
Interest coverage ratio: 7.510591494215415
COGS to revenue (%): 33.23597738870905
SG&A to revenue (%): 3.7818630348851703
Free cash flow (dilution-adjusted): 76237000
Buyback yield (%): 2.303002650035529
Retained earnings: 1833145000
Receivables turnover: 2.409091608929946
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.5600223985788486
FCF margin (%): 24.36146110608709
Revenue growth (%): 0.4577628685617065
Rule of 40 score: 24.819223974648796
Financial ratios for GPOR — annual report dated 2025-12-31
Total revenue: 1323527000
Gross profit: 935123000
Operating income: 501368000
Net income: 427810000
Capital expenditures: 527419000
Operating cash flow: 803193000
Depreciation & amortization: 304162000
Net tangible assets: 1834718000
Owner earnings: 204553000
Return on net tangible assets (%): 11.149015816054565
Capex to operating income (%): 105.19598378835506
Buffett classification: The Gruesome
Stock price: 207.99
P/E ratio: 8.73636808767911
Shares outstanding: 17969641
Book value: 1834718000
P/B ratio: 2.0371008686839067
Market cap (USD): 3737505631.59
Debt to equity: 0.4299009439052759
Current ratio: 0.6821629563839615
Quick ratio: 0.6821629563839615
Effective tax rate (%): 21.257857004813136
Interest coverage ratio: 10.228034027621943
COGS to revenue (%): 29.346133475176554
SG&A to revenue (%): 3.2102102941609805
Free cash flow (dilution-adjusted): 263468000
Buyback yield (%): 9.026983053841473
Retained earnings: 1834716000
Receivables turnover: 6.824731476659224
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.814872578706463
FCF margin (%): 19.906507385191237
Revenue growth (%): 42.528677455621555
Rule of 40 score: 62.435184840812795
Financial ratios for GPOR — quarterly report dated 2025-12-31
Total revenue: 355489000
Gross profit: 248270000
Operating income: 135954000
Net income: 132415000
Capital expenditures: 144670000
Operating cash flow: 185432000
Depreciation & amortization: 81681000
Net tangible assets: 1834718000
Owner earnings: 69426000
Return on net tangible assets (%): 3.784014764121789
Capex to operating income (%): 106.41099195316063
Buffett classification: The Gruesome
Stock price: 207.99
P/E ratio: 8.73636808767911
Shares outstanding: 17969641
Book value: 1834718000
P/B ratio: 2.0371008686839067
Market cap (USD): 3737505631.59
Debt to equity: 0.4299009439052759
Current ratio: 0.6821629563839615
Quick ratio: 0.6821629563839615
Effective tax rate (%): 19.7514029792856
Interest coverage ratio: 11.079292641186537
COGS to revenue (%): 30.160989510223946
SG&A to revenue (%): 3.0172522919133926
Free cash flow (dilution-adjusted): 37851000
Buyback yield (%): 3.6919543032580777
Retained earnings: 1834716000
Receivables turnover: 1.833069493789028
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.101955423093334
FCF margin (%): 10.647586845162579
Revenue growth (%): 13.596173080548729
Rule of 40 score: 24.24375992571131
Financial ratios for HAPV3.SA — annual report dated 2021-12-31
Capital expenditures: 105529084.3806104
Buffett classification: The Gruesome
Stock price: 27.31578947368421
Shares outstanding: 475087930
Market cap (USD): 12977401877.36842
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HAPV3.SA — annual report dated 2022-12-31
Total revenue: 4497879356.060606
Gross profit: 1071040909.090909
Operating income: 9301136.363636363
Net income: -146939204.54545453
Capital expenditures: 40203219.696969695
Operating cash flow: 184073295.45454544
Depreciation & amortization: 414258143.93939394
Net tangible assets: -277324053.030303
Owner earnings: 227115719.69696972
Capex to operating income (%): 432.2398696803095
Buffett classification: The Gruesome
Stock price: 14.459203036053133
Shares outstanding: 475087930
Book value: 9336961363.636364
P/B ratio: 0.7357203882841012
Market cap (USD): 6869392839.848198
Debt to equity: 0.2853542766533366
Current ratio: 1.1849564739889926
Quick ratio: 1.140894676140081
Interest coverage ratio: 0.030562408051399113
COGS to revenue (%): 76.18786934229907
SG&A to revenue (%): 8.434370355423807
Free cash flow (dilution-adjusted): 51764772.72727272
Buyback yield (%): 0.35276705103955086
Retained earnings: 0
Inventory turnover: 64.44568829494335
Receivables turnover: 58.87043142426526
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.07487669359157961
FCF margin (%): 1.1508706354589744
Rule of 40 score: 1.1508706354589744
Financial ratios for HAPV3.SA — annual report dated 2023-12-31
Total revenue: 5762798556.701032
Gross profit: 656087628.8659794
Operating income: 347911958.76288664
Net income: -126727628.86597939
Capital expenditures: 50272164.94845361
Operating cash flow: 481374432.9896908
Depreciation & amortization: 335076494.8453609
Net tangible assets: -124482268.04123712
Owner earnings: 158076701.0309279
Capex to operating income (%): 14.449680064810803
Buffett classification: The Great
Stock price: 13.819875776397515
Shares outstanding: 475087930
Book value: 10243908659.793816
P/B ratio: 0.6409327136267133
Market cap (USD): 6565656175.465838
Debt to equity: 0.2991855537100982
Current ratio: 1.4630228251161923
Quick ratio: 1.4120195768717825
Interest coverage ratio: 0.7368251210995002
COGS to revenue (%): 88.61512123995597
SG&A to revenue (%): 1.9687635299473087
Free cash flow (dilution-adjusted): 434397525.77319586
Buyback yield (%): 0.07596856914598489
Inventory turnover: 77.73747430203542
Receivables turnover: 58.75054494853206
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.519910245316456
FCF margin (%): 7.537961313398239
Revenue growth (%): 28.122568448529584
Rule of 40 score: 35.660529761927826
Financial ratios for HAPV3.SA — quarterly report dated 2024-09-30
Capital expenditures: 16361694.29097606
Buffett classification: The Gruesome
Stock price: 11.049723756906078
Shares outstanding: 475087930
Market cap (USD): 5249590386.740332
Buyback yield (%): 0
Retained earnings: -73174585.63535912
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HAPV3.SA — annual report dated 2024-12-31
Total revenue: 4678753721.682848
Gross profit: 534102427.18446606
Operating income: 280471035.59870553
Net income: -105064886.7313916
Capital expenditures: 47384627.83171521
Operating cash flow: 441137864.0776699
Depreciation & amortization: 277785922.3300971
Net tangible assets: -130022977.34627832
Owner earnings: 125336407.76699026
Capex to operating income (%): 16.894659988888318
Buffett classification: The Great
Stock price: 5.403877221324717
Shares outstanding: 475087930
Book value: 7876524757.281553
P/B ratio: 0.3259453784716316
Market cap (USD): 2567316843.053312
Debt to equity: 0.3393740191835873
Current ratio: 2.1086452314382167
Quick ratio: 2.0388459385973166
Interest coverage ratio: 0.8416194261214521
COGS to revenue (%): 88.584515044909
SG&A to revenue (%): 1.1238229083354079
Free cash flow (dilution-adjusted): 377131553.39805824
Buyback yield (%): 1.3917354609484955
Inventory turnover: 69.90171329701879
Receivables turnover: 57.960618841056146
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.539653240265174
FCF margin (%): 8.060513030431789
Revenue growth (%): -18.81108326713324
Rule of 40 score: -10.750570236701453
Financial ratios for HAPV3.SA — quarterly report dated 2024-12-31
Capital expenditures: 248867.3139158576
Buffett classification: The Gruesome
Stock price: 5.403877221324717
Shares outstanding: 475087930
Market cap (USD): 2567316843.053312
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0